NEFL and myeloid sarcoma: ACON aims to collect data on NfL and GFAP in the serum and CSF of patients following acute ON and to investigate their patterns in MS-ON, AQP4-IgG+ON, MOG-IgG+ON and also in double-seronegative non-MS-ON.